New Frontiers in Clinical Chemistry and Immunodiagnostics: Global Challenges, Emerging Technologies, Competitive Landscape is VPGMarketResearch.com new seven-country strategic analysis of major business opportunities emerging in the global clinical chemistry and immunodiagnostic markets during the next five years. The report explores future trends in the U.S., five major European countries (France, Germany, Italy, Spain, UK) and Japan; provides estimates of the specimen, test and sales volumes, as well as major suppliers sales and market shares; compares features of leading analyzers; profiles key competitors; and identifies specific product and marketing opportunities emerging during the next five years. Research Beam Model: Research Beam Product ID: 174911 21800 USD New
2014-2018 World Clinical Chemistry and Immunodiagnostic Markets: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies-France, Germany, Italy, Japan, Spain, UK, US
 
 

2014-2018 World Clinical Chemistry and Immunodiagnostic Markets: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies-France, Germany, Italy, Japan, Spain, UK, US

  • Category : Diagnostic and Biotech
  • Published On : November   2014
  • Pages : 1115
  • Publisher : VPGMarketResearch.com
 
 
 


New Frontiers in Clinical Chemistry and Immunodiagnostics: Global Challenges, Emerging Technologies, Competitive Landscape is VPGMarketResearch.com new seven-country strategic analysis of major business opportunities emerging in the global clinical chemistry and immunodiagnostic markets during the next five years. The report explores future trends in the U.S., five major European countries (France, Germany, Italy, Spain, UK) and Japan; provides estimates of the specimen, test and sales volumes, as well as major suppliers’ sales and market shares; compares features of leading analyzers; profiles key competitors; and identifies specific product and marketing opportunities emerging during the next five years.



The report provides five-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in hospitals, commercial laboratories, physician offices, and ambulatory care centers, including controls, calibrators and consumables.



Rationale



The clinical chemistry and immunodiagnostic markets are undergoing significant transformation, caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments, like routine chemistry, are already resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace creates exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, and calibrators.



Geographic Coverage



France, Germany, Italy, Japan, Spain, UK, USA 



Worldwide Market Overview



- Estimates of facilities performing clinical chemistry and immunodiagnostic tests by country.



- Test volume and sales projections by country.



Strategic Recommendations



- New product development opportunities with significant market appeal.



- Alternative market penetration strategies.



- Potential market entry barriers and risks.



Market Segmentation Analysis



- Comprehensive review of the market dynamics, trends, structure, size, growth, and key suppliers, by country.



- Test volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays, by country and market segment:Hospitals ; Commercial/Private Laboratories ; Physician Offices/Group Practices ; Ambulatory Care Centers 



Tests Analyzed in the Report



Routine Clinical Chemistry



Albumin, Alkaline Phosphatase, ALT/SGPT, Ammonia, Amylase, AST/SGOT, Bilirubin, Total, BUN (Blood Urea Nitrogen), Calcium, Cardio CRP, Carbon Dioxide/Bicarbonate, Chloride, Cholesterol, Creatine Kinase (CK), CK-MB, Creatinine, CRP, Ferritin, GGT, Glucose, HDL Cholesterol, Homocysteine, Iron, LDH, LDL Cholesterol, Magnesium, Phosphorus, Potassium, Protein, Total, Sodium, Triglycerides, Troponin, Uric Acid. 



Therapeutic Drug Monitoring (TDM)



Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid, Vancomycin.



Endocrine Function



Cortisol, Estradiol, FSH, HCG, Gastrin, LH, Progesterone, PTH/IO PTH, Prolactin, T3, T3 Uptake, Free T3, T4, Free T4, TBG, Testosterone, Thyroglobulin Ab, TPO Ab, TSH.



Tumor Markers and Special Chemistry



AFP, CA 15-3/27-29, CA 19-9, CEA, Ferritin, Follate (Folic Acid), Glycosylated Hemoglobin, HCG, 25-Hydroxy Vitamin D2 and D3, Occult Blood, PAP, PSA, Thyroglobulin, Vitamin B-12.



Immunoproteins



C3, C4, Free Light Chains, Haptoglobin, IgA, IgE Specific, IgE Total, IgG, IgM, Immunofixation, Prealbumin, Protein Electrophoresis.



Drugs of Abuse



Amphetamines, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP), Propoxyphene, Tricyclic Antidepressants.



Current and Emerging Products



- Analysis of current and emerging clinical chemistry and immunodiagnostic tests.



- Review of current instrumentation technologies, and feature comparison of high-, medium-, and low-volume/POC analyzers.



Technology Review



- Assessment of current and emerging technologies, and their potential market applications.



- Comprehensive lists of companies developing or marketing new technologies and products by test.



Competitive Assessments



- Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R&D.



- The companies analyzed in the report include: 



- Abbott Laboratories - AdnaGen - Agilent Technologies - Beckman Coulter/Danaher - Biomedical Diagnostics - BioMerieux - Bio-Rad - DiaSorin - Eiken - Fujirebio/Innogenetics - Instrumentation Laboratory - Kyowa Medex - Matritech/Alere - Ortho-Clinical Diagnostics - Quest Diagnostics - Roche - Siemens - Sysmex - Thermo Fisher - Tosoh - Wako - Wallac/PE



Contains 1,115 pages and 450 tables 



Please note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch.




../toc/TOCLOTNewFrontiersinCCandImmunodiagnosticsGlobalChallengesEmergingTechCompetitiveLandscape.pdf
PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter

 
 
REQUEST SAMPLE    ASK FOR DISCOUNT